Search
There is a growing space for cannabis players on the ASX.

Study cool on cannabis pain benefit

A University of New South Wales study has called for caution about the potential benefits of medicinal cannabis to relieve pain, but a Western Australian hopeful in the sector is still confident for the future of the industry.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Total Shareholder Return as at 28/09/18

1 year TSR5 year TSR
65thAusCann Group Holdings116%61%
567thPhylogica-23%17%
705thNeurotech International-46%0%
809thTech Mpire-73%-18%
739 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

09/08/18
$15k Issued
10/05/17
$0 Other
10/05/17
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

209th↓Tech Mpire$73k
210th↓Neurotech International$67k
211th↓AusCann Group Holdings$54k
212th↓Activistic$49k
213th↓Phylogica$48k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer